LARGE Antikörper (AA 35-142) (PE)

Produktnummer ABIN5541531

Produktdetails anti-LARGE Antikörper (PE)

Target: LARGE (Like-Glycosyltransferase (LARGE))

Bindungsspezifität: AA 35-142

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser LARGE Antikörper ist konjugiert mit PE

Applikation: Flow Cytometry (FACS)

Spezifität: Thisa ntibody recognizes human LARGE1, a glycosyltransferase localizing mainly to the Golgi apparatus. Crossreactivity with LARGE2 was not determined.

Immunogen: Recombinant fragment of human LARGE1 (amino acids 35-142)

Klon: LARGE-02

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise: Flow cytometry.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store the antibody at 2-8°C. DO NOT FREEZE! This product is photosensitive and should be protected from light. Shelf life: one year from despatch.

Haltbarkeit: 12 months

Details zu LARGE

Target: LARGE (Like-Glycosyltransferase (LARGE))

Andere Bezeichnung: large (LARGE Produkte)

Synonyme: gyltl1b antikoerper, gyltl1b-b antikoerper, mdc1d antikoerper, MDC1D antikoerper, MDDGA6 antikoerper, MDDGB6 antikoerper, BPFD36 antikoerper, Gyltl1a antikoerper, Mbp-1 antikoerper, Mbp1 antikoerper, enr antikoerper, fg antikoerper, froggy antikoerper, mKIAA0609 antikoerper, myd antikoerper, NV15834 antikoerper, DKFZp459G0120 antikoerper, LARGE xylosyl- and glucuronyltransferase 1 L homeolog antikoerper, LARGE xylosyl- and glucuronyltransferase 1 antikoerper, glycosyltransferase-like protein LARGE1 antikoerper, like-glycosyltransferase antikoerper, large1.L antikoerper, LARGE1 antikoerper, Large1 antikoerper, large1 antikoerper, LOC100118066 antikoerper, LARGE antikoerper, Large antikoerper

Hintergrund: LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.

UniProt: O95461